跳至主要内容
临床试验/ISRCTN15513131
ISRCTN15513131已完成未知

How can we optimise inhaled beta2 agonist dose as 'reliever' medicine for wheezy preschool children?

Brighton and Sussex University Hospitals NHS Trust0 个研究点目标入组 84 人开始时间: 2015年4月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
84

研究概览

简要总结

2016 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/27836009 protocol

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age 2 years 6 months to 6 years 11 months
  • 2. Recurrent wheeze, defined as at least 3 episodes of wheeze over the previous 12 months by the parent

排除标准

  • 1. Other major airway or lung disease, e.g. chronic lung disease of prematurity, cystic fibrosis, and abnormal airway anatomy
  • 2. Recent (within 2 weeks) treatment with systemic corticosteroids or leukotriene inhibitors
  • 3. Participants involved in other research currently or recently

研究者

发起方
Brighton and Sussex University Hospitals NHS Trust

相似试验